CDH2 and large cell neuroendocrine carcinoma: Furthermore, our analyses revealed that increased intensity of STXBP1, EMILIN2, and CDH2 was associated with poor prognosis in LCNEC and SCLC (Fig. 5F and Fig. S12C and D).